The association between organised colorectal cancer screening strategies and reduction of its related mortality: a systematic review and meta-analysis
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Background: To assess the long-term association between organised colorectal cancer (CRC) screening strategies and CRC-relate mortality. Methods: We systematically reviewed studies on organised CRC screening through PubMed, Ovid Medline, Embase and Cochrane from the inception. We retrieved characteristics of organised CRC screening from included literature and matched mortality (over 50 years) of those areas from the International Agency for Research on Cancer in May 2023. The variations of mortality were reported via the age-standardised mortality ratio. A random-effects model was used to synthesis results. Results: We summarised 58 organised CRC screening programmes and recorded > 2.7 million CRC-related deaths from 22 countries where rollout screening programmes were performed. The CRC screening strategy with faecal tests (guaiac faecal occult blood test (gFOBT) or faecal immunochemical tests (FIT)) or colonoscopy as the primary screening offer was associated with a 41.8% reduction in mortality, which was higher than those offered gFOBT (4.4%), FIT (16.7%), gFOBT or FIT (16.2%), and faecal tests (gFOBT or FIT) or flexible sigmoidoscopy (16.7%) as primary screening test. The longer duration of screening was associated with a higher reduction in the pooled age-standardised mortality ratio. In particular, the pooled age-standardised mortality ratio became non-significant when the screening of FIT was implemented for less than 5 years. Conclusions: A CRC screening programme running for > 5 years was associated with a reduction of CRC-related mortality. Countries with a heavy burden of CRC should implement sustainable, organised screening providing a choice between faecal tests and colonoscopy as a preferred primary test.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A modern meta-analysis demonstrates that the reduction in mortality as a result of CRC screening increases with a screening duration of more than 5 years[41].”
From Risk factors, prevention and screening of colorectal cancer: A rising problem (2025) · cites this paper as [41]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Agency for Research on Cancer
National Cancer Institute (2020) · Definitions · doi:10.32388/pfg7jq · Cited by 9,435
Assessing heterogeneity in meta-analysis: Q statistic or I² index?
Huedo-Medina, T. B., Sánchez-Meca, J., Marín-Martínez, F., & Botella, J. (2006) · Psychological Methods · doi:10.1037/1082-989x.11.2.193 · Cited by 4,256 · cited 1×
“I 2 was reported to evaluate the heterogeneity, and I 2 of 25%, 50%, and 75% indicated low, medium, and high heterogeneity, respectively [11].”
BackgroundEdwards, B. K., Ward, E., Kohler, B. A., Eheman, C., Zauber, A. G., Anderson, R. N., Jemal, A., Schymura, M. J., Lansdorp‐Vogelaar, I., Seeff, L. C., et al. (2010) · Cancer · doi:10.1002/cncr.24760 · Cited by 2,002 · cited 1×
“These include people’s attitude to CRC screening, changes in lifestyle habits over time, and the development of novel cancer treatments that were not able to be accounted for, although a study from the US suggested that only 12% of mortality decline was attributed to treatment [29].”
BackgroundScreening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-9-200811040-00243 · Cited by 1,959 · cited 1×
“The United States Preventive Services Task Force indicated that it should take at least seven years to observe the benefit of CRC screening [22].”
BackgroundColorectal cancer screening: a global overview of existing programmes
Schreuders, E. H., Ruco, A., Rabeneck, L., Schoen, R. E., Sung, J. J. Y., Young, G. P., & Kuipers, E. J. (2015) · Gut · doi:10.1136/gutjnl-2014-309086 · Cited by 1,328 · cited 2×
“Nevertheless, the traditional opportunistic screening approach is largely performed only when a patient visits a physician, which may lead to under-or over-screening, uncertain quality, or health inequity [2].”
BackgroundResultBrenner, H., Stock, C., & Hoffmeister, M. (2014) · BMJ · doi:10.1136/bmj.g2467 · Cited by 866 · cited 1×
“Faecal tests and colonoscopy subgroup involved Czech Republic and Israel Besides these two screening strategies, colonoscopy was found to be associated with a 61–68% decline in CRC-related mortality [14, 17, 18].”
MethodLevin, T. R., Corley, D. A., Jensen, C. D., Schottinger, J. E., Quinn, V. P., Zauber, A. G., Lee, J. K., Zhao, W. K., Udaltsova, N., Ghai, N. R., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.07.017 · Cited by 554 · cited 1×
“The higher rates of screening were associated with a reduction from 30.9 to 14.7 deaths/100,000 [7].”
BackgroundInfluentialHol, L., van Leerdam, M. E., van Ballegooijen, M., van Vuuren, A. J., van Dekken, H., Reijerink, J. C. I. Y., van der Togt, A. C. M., Habbema, J. D. F., & Kuipers, E. J. (2010) · Gut · doi:10.1136/gut.2009.177089 · Cited by 481 · cited 1×
“Existing evidence suggests that FIT had better performance than gFOBT due to the higher participation rate and higher detection rate of CRC [12, 13].”
BackgroundCardoso, R., Guo, F., Heisser, T., Hackl, M., Ihle, P., De Schutter, H., Van Damme, N., Valerianova, Z., Atanasov, T., Májek, O., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00199-6 · Cited by 480 · cited 1×
“The average annual percentage changes were employed by Cardoso et al. to compare the epidemiological changes of CRC in relation to screening implementation across Europe [9].”
MethodAn updated Asia Pacific Consensus Recommendations on colorectal cancer screening
Sung, J. J. Y., Ng, S. C., Chan, F. K. L., Chiu, H. M., Kim, H. S., Matsuda, T., Ng, S. S. M., Lau, J. Y. W., Zheng, S., Adler, S., et al. (2015) · Gut · doi:10.1136/gutjnl-2013-306503 · Cited by 411
Cited by
Risk factors, prevention and screening of colorectal cancer: A rising problem
Tsukanov, V. V., Vasyutin, A. V., & Tonkikh, J. L. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i5.98629 · Cited by 42
Global colorectal cancer screening programs and coverage rate estimation: an evidence synthesis
Chen, Y., Zhang, Y., Yan, Y., Han, J., Zhang, L., Cheng, X., Lü, B., Li, N., Luo, C., Zhou, Y., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06887-4 · Cited by 44
“There is clear evidence that organized screening programs can significantly reduce CRC mortality [49].”
Surgical Emergencies in Rectal Cancer: A Narrative Review
Pajola, M., Fugazzola, P., Cobianchi, L., Frassini, S., Ghaly, A., Bianchi, C. M., & Ansaloni, L. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm14010126 · Cited by 13
Zeng, X., Wang, J., Liu, N., Chen, L., Liang, L., Zhuo, L., Zhang, X., & Lin, M. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1673341 · Cited by 11
Wang, Z., Sun, Z., Lv, H., Wu, W., Li, H., & Jiang, T. (2024) · Scientific Reports · doi:10.1038/s41598-024-75270-y · Cited by 10
Metadata
- Authors
- Ding, H., Lin, J., Xu, Z., Wang, H. H. X., Huang, L., Huang, J., & Wong, M. C. S.
- Affiliations
- Chinese University of Hong Kong (HK)
- Corresponding author
- Wong, Martin C. S.
- Venue
- BMC Cancer
- Published
- 2024-03-21
- Volume
- 24
- Issue
- 1
- Pages
- 365-365
- ISSN
- 1471-2407 (ISSN-L)
- OpenAlex
- W4393040387
- Semantic Scholar
- 9911dd3d93a44a963cb410ec9aea46bc2597e9f9
- Cited by
- 28
- References
- 26
- Citations by year
- 2026: 15 · 2025: 9 · 2024: 4
- FWCI
- 1.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- BMC Cancer (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Keywords
- colorectal cancer screening, organized screening programs, colorectal cancer mortality, fecal immunochemical test, guaiac fecal occult blood test, colonoscopy, flexible sigmoidoscopy
- MeSH terms
- Child, Preschool, Colonoscopy, Guaiac, Humans, Mass Screening, Middle Aged, Occult Blood, Colorectal Neoplasms, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The association between organised colorectal cancer screening strategies and reduction of its related mortality: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1186/s12885-024-12054-7
- The paper
- Ding, H., Lin, J., Xu, Z., Wang, H. H. X., Huang, L., Huang, J., & Wong, M. C. S. (2024). The association between organised colorectal cancer screening strategies and reduction of its related mortality: a systematic review and meta-analysis. BMC Cancer. https://doi.org/10.1186/s12885-024-12054-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.


